Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Trends in Pharmacological Sciences|August 25, 2020
Fruitful Neutralizing Antibody Pipeline Brings Hope To Defeat SARS-Cov-2Alex Renn, Ying Fu, Xin Hu, et al.International Immunopharmacology|December 4, 2018
Preclinical development of the TLR9 agonist DV281 as an inhaled aerosolized immunotherapeutic for lung cancer: Pharmacological profile in mice, non-human primates, and human primary cellsSariah A Kell, Melissa A Kachura, Alex Renn, et al.Molecular Cancer Therapeutics|March 21, 2022
GPC1-Targeted Immunotoxins Inhibit Pancreatic Tumor Growth in Mice via Depletion of Short-lived GPC1 and Downregulation of Wnt SignalingJiajia Pan, Nan Li, Alex Renn, et al.Journal of Neurosurgery|January 24, 2025
Association between pituitary adenoma consistency, resection techniques, and patient outcomes: a single-institution experienceGage A Guerra, Zain Kashif, David J Cote, et al.Operative Neurosurgery (Hagerstown, Md.)|July 7, 2025
Catalogue and Evolution of Minimally Invasive Approaches for Adult Intracranial Pathology From 2011 to 2023Max Yang, Ishan Shah, Alex Renn, et al.Journal of Neurosurgery|January 10, 2025
Association between meningioma consistency and surgical outcomesIshan Shah, Ryan S Chung, Kevin Liu, et al.Biorxiv : the Preprint Server for Biology|November 3, 2021
A humanized nanobody phage display library yields potent binders of SARS CoV-2 spikeYing Fu, Juliana da Fonseca Rezende E Mello, Bryan D Fleming, et al.Plos One|August 10, 2022
A humanized nanobody phage display library yields potent binders of SARS CoV-2 spikeYing Fu, Juliana da Fonseca Rezende E Mello, Bryan D Fleming, et al.Biorxiv : the Preprint Server for Biology|June 9, 2020
An OpenData portal to share COVID-19 drug repurposing data in real timeKyle R Brimacombe, Tongan Zhao, Richard T Eastman, et al.Pageof 1